uurimisrühmad - Stabilis 4.0

viimane versioon :
07/07/2025

uurimisrühmad - Hospital General Universitario Vall d\'Hebron

Hospital General Universitario Vall d\'Hebron

Barcelone

Viited

(5)

Physical Compatibility Between Intravenous Magnesium Sulfate and Potassium or Sodium Phosphate in a Pediatric Intensive Care Unit.
Bautista S.C, Lozano I.J, Belles L.C, Parramón-Teixidó C.J, Esquerda C.G, Sanjuan A.P, Noves C.D, Encinas V.S, Maria Josep Caba ()
Hosp Pharm - 2024 - ; 59, 5:

Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner ()
SEFH Congress (Virtual) October 2021 - 2021 -

Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al. ()
Eur Hosp Pharm - 1997 - ; 3: 59-60.

Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material.
Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV. ()
Pharm World Sci - 1993 - ; 15: 34-36.

Stability of famotidine 20 and 40 mg/L in total nutrient admixtures.
Montoro JB, Pou L, Salvador P, Pastor C, Cano SM. ()
Am J Hosp Pharm - 1989 - ; 46: 2329-2332.

molekulid uuritud

(16)

		Amphotericin B
		Ampicillin sodium
		Atosiban
		Cisplatin
		Clindamycin phosphate
		Dexketoprofen
		Famotidine
		Gentamicin sulfate
		Labetalol hydrochloride
		Magnesium sulfate
		Metamizol sodium
		Metoclopramide hydrochloride
		Omeprazole sodium
		Paracetamol
		Potassium phosphate
		Sodium Phosphate

Mentions Légales